✦ LIBER ✦

Effects of diet and the cholecystokinin antagonist; devazepide (L364, 718) on CCK mRNA, and tissue and plasma CCK concentrations

✍ Scribed by R. J. PLAYFORD; A. W. KING; P. H. DEPREZ; J. DE-BELLEROCHE; T. C. FREEMAN; J. CALAM

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Time course of effect of devazepide (L36

✍ R.J. Playford; P.H. Deprez; J. Gill; J. de Bellaroche; J. Calam 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Effects of intraduodenal administration

✍ Naoko Sazaki; Kyoko Miyasaka; Masahiro Matsumoto; Akihiro Funakoshi 📂 Article 📅 1995 🏛 Springer Japan 🌐 English ⚖ 752 KB

Ornithine decarboxylase and polyamines i

✍ CHR. LÖSER; U. R. FÖLSCH; P. SAHELIJO-KROHN; W. CREUTZFELDT 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 831 KB

Ability of L365,260 and L364,718 to anta

✍ E. Fernàndez; P. Gascó; E. Goñalons-Montaner; A. Rodríguez-Sinovas; M.T. Martín; 📂 Article 📅 1992 🏛 Elsevier Science 🌐 English ⚖ 62 KB

The CCK-A receptor antagonist devazepide

✍ Yoshio Minabe; Charles R. Ashby Jr.; Rex Y. Wang 📂 Article 📅 1991 🏛 Elsevier Science 🌐 English ⚖ 341 KB

Effect of metoclopramide, bethanechol an

✍ Dennis L. Decktor; Robert G. Pendleton; Anne T. Elnitsky; Ann M. Jenkins; Anthon 📂 Article 📅 1988 🏛 Elsevier Science 🌐 English ⚖ 651 KB